This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Netflix, Medicis, Korn/Ferry Are Market Movers

NEW YORK (AP) â¿¿ Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and Nasdaq Stock Market:

NYSE

Consol Energy Inc., down $1.37 at $28.83

The coal and natural gas company is temporarily idling its coal mine in Virginia because of weaker global demand for steel.

Medicis Pharmaceutical Corp., up $12.09 at $43.65

The dermatology products maker agreed to be bought by Valeant Pharmaceuticals International Inc. in a $2.6 billion deal.

Heckmann Corp., up $1.02 at $3.71

The water management firm is buying privately held Power Fuels in a $381 million deal to raise its foothold in the fracking market.

Korn/Ferry International, up 78 cents at $15.08

The staffing firm said it purchased Global Novations LLC in a move to bolster its leadership and talent consulting business.

Accretive Health Inc., up 79 cents at $12.68

The company, which helps hospitals manage their revenue, said that its board approved the repurchase of $50 million in stock.

Nasdaq

Netflix Inc., down $3.79 at $55.93

Amazon.com, which has a rival online streaming service to Netflix, signed a deal with Epix to license movies from Paramount, MGM and Lionsgate.

Tower Semiconductor Ltd., up 81 cents at $8.71

The chip maker expanded its product-making deal with Vishay Intertechnology for five years. Tower expects it will boost its revenue.

Medivation Inc., up $4.35 at $109.21

The drugmaker said that it received approval from the Food and Drug Administration for its drug Xtandi, which treats prostate cancer.

Copyright 2011 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,136.16 +94.62 0.52%
S&P 500 2,114.19 +9.99 0.47%
NASDAQ 5,065.9740 +33.2230 0.66%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs